retatrutide while pregnant Injection: Package Insert / Prescribing Info Retatrutide Achieves Up to 30.3%

Some CV benefit may be expected, given some similarity in action to the GLP-1 analogues

The analysis was supported by grant from the National Research Foundation of Korea grant

Diabetes Care , 48 (2), 177181

Diabetes Obes Metab 25(1):5667 Rosenstock J, Wysham C, Frias JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

Within research settings, Cagrilintide is widely studied in relation to: Sense of satiety and appetite suppression Reduced food intake in research models The role of amylin within metabolism Long-term regulation of eating behavior Why is Cagrilintide often investigated along with Retatrutide

Cell 172 , 393407 (2018)